AQR Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.47M Buy
135,216
+33,962
+34% +$1.44M ﹤0.01% 1823
2025
Q4
$4.69M Buy
101,254
+14,070
+16% +$589K ﹤0.01% 1596
2025
Q3
$3.05M Sell
87,184
-3,200
-4% -$111K ﹤0.01% 1733
2025
Q2
$2.67M Sell
90,384
-16,988
-16% -$485K ﹤0.01% 1611
2025
Q1
$3.21M Sell
107,372
-46,844
-30% -$1.43M ﹤0.01% 1349
2024
Q4
$4.42M Buy
154,216
+25,206
+20% +$834K 0.01% 1157
2024
Q3
$4.98M Buy
129,010
+27,054
+27% +$965K 0.01% 1063
2024
Q2
$3.28M Sell
101,956
-7,170
-7% -$249K 0.01% 1236
2024
Q1
$4.24M Buy
109,126
+3,960
+4% +$139K 0.01% 1051
2023
Q4
$3.24M Buy
105,166
+732
+0.7% +$18.3K 0.01% 1142
2023
Q3
$2.33M Buy
104,434
+55,138
+112% +$1.26M ﹤0.01% 1260
2023
Q2
$1.06M Buy
49,296
+33,912
+220% +$770K ﹤0.01% 1527
2023
Q1
$369K Buy
15,384
+5,611
+57% +$149K ﹤0.01% 1876
2022
Q4
$227K Buy
+9,773
New +$197K ﹤0.01% 2049
2022
Q3
Sell
-75,227
Closed -$1.33M 2217
2022
Q2
$1.33M Buy
75,227
+40,806
+119% +$686K ﹤0.01% 1294
2022
Q1
$701K Buy
34,421
+20,265
+143% +$383K ﹤0.01% 1692
2021
Q4
$264K Buy
14,156
+1,008
+8% +$19.6K ﹤0.01% 2019
2021
Q3
$260K Sell
13,148
-468
-3% -$10.1K ﹤0.01% 2076
2021
Q2
$322K Buy
13,616
+931
+7% +$21.5K ﹤0.01% 2033
2021
Q1
$301K Sell
12,685
-24,253
-66% -$576K ﹤0.01% 2003
2020
Q4
$740K Sell
36,938
-19,550
-35% -$382K ﹤0.01% 1636
2020
Q3
$1.18M Sell
56,488
-9,928
-15% -$179K ﹤0.01% 1336
2020
Q2
$1.16M Sell
66,416
-27,566
-29% -$540K ﹤0.01% 1400
2020
Q1
$1.53M Buy
93,982
+82,485
+717% +$1.7M ﹤0.01% 1174
2019
Q4
$237K Buy
+11,497
New +$192K ﹤0.01% 1968
2019
Q3
Sell
-24,334
Closed -$320K 2116
2019
Q2
$320K Buy
+24,334
New +$325K ﹤0.01% 1864
2019
Q1
Sell
-17,335
Closed -$298K 2174
2018
Q4
$298K Sell
17,335
-3,312
-16% -$56.7K ﹤0.01% 1962
2018
Q3
$304K Sell
20,647
-3,849
-16% -$68.2K ﹤0.01% 2102
2018
Q2
$584K Buy
+24,496
New +$602K ﹤0.01% 1925

Other funds holding COLL